Explore
Trendline
Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026
Enanta Pharmaceuticals Reports Decreased Net Loss Amid Financial Results for Q2 2026
Read More
Trendline
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Agenus Inc Reports Significant Revenue Growth and Profit in Q1 2026
Read More
Trendline
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Lantern Pharma to Announce Q1 2026 Financial Results, Highlighting AI-Driven Oncology Developments
Read More
Trendline
Rosen Law Firm Investigates Immutep Ltd. for Securities Class Action
Rosen Law Firm Investigates Immutep Ltd. for Securities Class Action
Read More
Trendline
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Lantern Pharma to Announce Q1 2026 Financial Results Amid AI-Driven Oncology Developments
Read More
Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for AI-Driven Development
Read More
Trendline
Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment
Veradermics Reports Q1 2026 Financial Results and Clinical Progress in Hair Loss Treatment
Read More
Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Read More
Trendline
AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs
AN2 Therapeutics Reports Q1 2026 Financial Results and Advances Clinical Programs
Read More
Trendline
Coya Therapeutics Reports Financial Results and Advances ALS Treatment
Coya Therapeutics Reports Financial Results and Advances ALS Treatment
Read More
Trendline
enGene Faces Stock Plunge Amid Declining Response Rates in Bladder Cancer Therapy
enGene Faces Stock Plunge Amid Declining Response Rates in Bladder Cancer Therapy
Read More
Trendline
Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies
Bio-Rad Laboratories to Engage in Key Investor Conferences Highlighting Financial Strategies
Read More
